# Insocius: Business Description

Insocius is a London-based consulting firm specialising in strategic and operational challenges within the pharmaceutical and biotech sectors. With a global team of 50 senior consultants, they partner with industry leaders to accelerate performance, drive transformational change, and strengthen executive capabilities.

The firm serves pharma and biotech organisations facing complex strategic decisions, organisational restructuring, and leadership transitions. Their client base includes C-suite executives and senior teams across global, regional, and country operations who need to navigate competitive pressures, scientific communication challenges, and stakeholder management.

What distinguishes Insocius is their proprietary methodology combining deep industry expertise with behavioural change, communication strategy, and executive coaching. Rather than offering generic consulting, they develop bespoke solutions addressing the specific dynamics of regulated healthcare markets. Their approach recognises the diverse stakeholder landscape pharma companies navigate—patients, physicians, payers, policy-makers, and employees—each requiring distinct messaging and engagement strategies.

The firm structures its work around three branded offerings: Articulation™ (clarifying organisational and brand value proposition), Catalysis™ (accelerating team implementation of strategy), and Transformation™ (embedding commitment and capability during business change). This framework reflects their belief that successful pharma strategy requires not just analytical rigour but sustained behaviour change and stakeholder alignment. Their positioning as an "organisation enabler" emphasises enabling existing teams rather than replacing internal capability—a consultative approach appealing to mature, sophisticated healthcare organisations.